Michael F. Cola
Net Worth

Last updated: 7 Sep 2025

What is Michael F. Cola net worth?

The estimated net worth of Mr. Michael F. Cola is at least $3,304,876 as of 7 Sep 2025. He owns shares worth $514,936 as insider and has received compensation worth at least $2,789,940 in Avalo Therapeutics, Inc. and Cerecor Inc..

What is the salary of Michael F. Cola?

Mr. Michael F. Cola salary is $464,990 per year as Chief Executive Officer & Director in Avalo Therapeutics, Inc.. He also receives $464,990 as Chief Executive Officer, Pres & Director in Cerecor Inc..

How old is Michael F. Cola?

Mr. Michael F. Cola is 65 years old, born in 1960.

What stocks does Michael F. Cola currently own?

As insider, Mr. Michael F. Cola owns shares in one company:

Company	Title	Shares	Price per share	Total value
Cerecor Inc. (CERC)	Chief Executive Officer, Pres & Director	175,746	$2.93	$514,936

What does Cerecor Inc. do?

Cerecor Inc., a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.